The flyer explains how biosimilar medicines, such as Jubbonti (denosumab), can improve patient access while reducing PBS costs. It highlights short- and long-term price reductions, increased prescription volumes, and significant PBS savings that can be reinvested into funding new medicines and treatments.

Leadtime:
Production: 2-4 working days
Delivery 3-6 working days